Macahis, Azuryn B.

HRN: 26-03-63  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/14/2026
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
03/14/2026
03/21/2026
IV DRIP
500mg
Q6
PCAP-C
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: